IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factor. NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factor.

Princess Takamatsu Symp. 1988;19:73-86. Unique Identifier : AIDSLINE MED/90062032
Yodoi J; Tagaya Y; Masutani H; Maeda Y; Kawabe T; Institute for Immunology, Faculty of Medicine, Kyoto University,; Japan.


Abstract: Lymphocyte transformation/activation is accompanied by the induction of a variety of the inducible receptors associated with the activation antigens. The p55 chain of the interleukin-2 receptor (IL-2R/p55) recognized by anti-Tac monoclonal antibody (mAb) is expressed on activated T and B cells as well as natural killer (NK) cells. IL-2R/p55(Tac) is constitutively expressed on T4(+) T cells transformed by human T-lymphotropic virus I (HTLV-I), which is a causative agent for adult T-cell leukemia (ATL). Low affinity Fc receptor for IgE (Fc epsilon R2/CD23) is another inducible receptor binding IgE and is expressed on various hematopoietic cell types. While the physiological expression of Fc epsilon R2 and its soluble form (IgE Binding Factor; IgE BF) is variably regulated by cytokines and IgE, there is a constitutive expression of Fc epsilon R2 on Epstein-Barr virus (EBV) transformed B cell lines and some of HTLV-I (+) T cell lines. ATL-derived factor (ADF) has been characterized as an IL-2R/p55(Tac) inducing factor derived from HTLV-I(+) T cell lines. Purification of ADF protein and the cDNA cloning proved that ADF is closely related to the autocrine growth factor produced by an EBV(+) B cell line 3B6 (H. Wakasugi and T. Tursz) and belonging to the family of thiol reducing co-enzyme thioredoxin which is involved in many biological reactions. Recombinant ADF produced by COS cells and E. coli showed both IL-2R inducing and reducing activities. We will discuss the biological roles of ADF in viral and normal lymphocyte activation and transformation in relation to the receptor gene activation.
Keywords: Amino Acid Sequence Antigens, Differentiation, B-Lymphocyte/BIOSYNTHESIS/*GENETICS Cell Transformation, Viral DNA/ANALYSIS *Gene Expression Regulation Human HTLV-I Infections/IMMUNOLOGY *Lymphocyte Transformation Neoplasm Proteins/ANALYSIS/GENETICS/*PHYSIOLOGY Receptors, Fc/BIOSYNTHESIS/*GENETICS Receptors, Interleukin-2/BIOSYNTHESIS/*GENETICS Support, Non-U.S. Gov't Thioredoxin/ANALYSIS JOURNAL ARTICLE REVIEW REVIEW, ACADEMICKWDaminoacidsequenceantigens,differentiation,b-lymphocyte/biosynthesis/KWDgeneticscelltransformation,viraldna/analysisKWDgeneexpressionregulationhumanhtlv-iinfections/immunologyKWDlymphocytetransformationneoplasmproteins/analysis/genetics/KWDphysiologyreceptors,fc/biosynthesis/KWDgeneticsreceptors,interleukin-2/biosynthesis/KWDgeneticssupport,non-uKWDsKWDgov'tthioredoxin/analysisjournalarticlereviewreview,academic
900330
M9030688

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .